Skip to main content

Series B Biotechnology Companies

Explore 430 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
430
Total Funding
$1.8B
Avg Funding
$71.6M
Cities
22

Export 430 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Cambridge, United States
$60.0M
raised

Ethyreal Bio is a biotechnology startup developing precision therapies for autoimmune thyroid disorders.

Jan 2026
Series B

Founder Contacts

41,000+ verified contacts

Boca Raton, United States
$50.0M
raised

Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Wakefield, United States
$30.5M
raised

Myrtelle is a gene therapy company that offers clinical trials for the treatment of rare monogenetic disorders.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Rochester, United States
$25.0M
raised

Vyriad is a clinical stage biopharmaceutical company.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$55.0M
raised

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$84.0M
raised

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Lexington, United States
$120.0M
raised

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$15.0M
raised

Iolyx Therapeutics is a biotechnology research and healthcare service provider for ocular diseases.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States
$10.0M
raised

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$130.0M
raised

Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.

Dec 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Brisbane, United States
$65.0M
raised

Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.

Nov 2025
Series B

Founder Contacts

41,000+ verified contacts

Paris, France
$17.4M
raised

DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.

Nov 2025
Series B

Founder Contacts

41,000+ verified contacts

Paris, France
$20.7M
raised

nextProtein develops a new large-scale technology that produces a sustainable source of protein.

Nov 2025
Series B

Founder Contacts

41,000+ verified contacts

Milano, Italy
$141.0M
raised

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

Nov 2025
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$47.0M
raised

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Seongnam, South Korea
$17.8M
raised

MediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Loos, France
$49.9M
raised

Lattice Medical offers a 3D printed bioabsorbable medical device for breast reconstruction.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Boulder, United States
$17.3M
raised

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Sunnyvale, United States
$28.0M
raised

BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States
$78.0M
raised

Peptilogics is a clinical-stage therapeutics company that develops peptide-based therapeutics using AI and computational biology.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
St Louis, United States
$5.8M
raised

Plastomics develops a new and better way to make the next generation of biotech crops using chloroplast engineering.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Waltham, United States
$600.0M
raised

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Rockville, United States
$50.0M
raised

OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$45.2M
raised

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$27.9M
raised

OXCCU develops technology to convert carbon dioxide and hydrogen into synthetic fuels, chemicals, and biodegradable plastics.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Showing 76 to 100 of 430 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 430 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked